Devra Densmore

Aug 26, 2024 | clinicalleader.com | Devra Densmore

Operationalizing A Diversity Action Plan That Makes An ImpactIn part two of this series on creating a diversity action plan (DAP), Elevate Advocacy's Devra Densmore shares a detailed plan for creating a DAP that meets FDA expectations. Accelerating Study Start-Up And Patient Recruitment For Clinical TrialsA network of proven and trusted sites means sponsors can progress quickly through the site selection process to study startup and then be assured of reliable patient recruitment and robust data.

Aug 19, 2024 | clinicalleader.com | Devra Densmore

By Devra Densmore, founder and principal consultant, Elevate Advocacy Although creating an ecosystem of support for a diversity action plan (DAP) is a critical first step, it is paramount that the plan drive representation within clinical research by its operationalization.

Aug 12, 2024 | clinicalleader.com | Devra Densmore

By Devra Densmore, founder and principal consultant, Elevate Advocacy Diversity Action Plans (DAPs) are a hot topic in the clinical development process, particularly now that the FDA released in June 2024 its revised guidance, Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies. This updated draft provides a much more robust blueprint for what is expected from clinical study sponsors.

Apr 19, 2024 | clinicalleader.com | Devra Densmore

By Devra Densmore, MPA, founder & principal consultant, Elevate Advocacy An informed consent form (ICF) is one of the most important documents a sponsor can produce for their clinical studies. For many study participants, it is their introduction to clinical research and the first information they have about the study.

Jan 22, 2024 | clinicalleader.com | Larry Ajuwon |Kerry Leyden |Caroline Potts |Devra Densmore

YPrime unveils a transformative brand focused on Solving for Certainty in clinical trials. Experience the reimagined brand and explore the solutions that transform clinical research at www.yprime.com. New Calculator Could Help Determine Costs And Fair CompensationPatients, sponsors, and other stakeholders could finally get help estimating patients' cost burdens thanks to the industry’s first open-access financial burden calculator. Will FDORA Impact My Clinical Research Practice?